References
- Folsom DP, Hawthorne W, Lindamer L, et al. Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am J Psychiatry. 2005;162:370–376.
- Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS. 2005;19:S26–S33.
- White MC, Chafetz L, Collins-Bride G, Nickens J. History of arrest, incarceration and victimization in community-based severely mentally ill. J Community Health. 2006;31:123–135.
- Bowser BP, Lewis D, Dogan D. External influences on drug treatment interventions: East Palo Alto's free-at-Last. J Addict Med. 2011;5:115–122.
- Coe AB, Moczygemba LR, Gatewood SB, et al. Medication adherence challenges among patients experiencing homelessness in a behavioral health clinic. Res Social Adm Pharm. 2015;11:e110–e120.
- Gonzalez G, Rosenheck RA. Outcomes and service use among homeless persons with serious mental illness and substance abuse. Psychiatr Serv. 2002;53:437–446.
- Morse GA, York MM, Dell N, Blanco J, Birchmier C. Improving outcomes for homeless people with alcohol disorders: a multi-program community-based approach. J Ment Health. 2017;7:1–8. doi:10.1080/09638237.2017.1340617
- Aubry T, Goering P, Veldhuizen S, et al. A multiple-city RCT of housing first with assertive community treatment for homeless Canadians with serious mental illness. Psychiatr Serv. 2016;67:275–281.
- Tracy K, Babuscio T, Nich C, et al. Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse. 2007;33:253–258.
- Milby JB, Schumacher JE, Wallace D, Freedman MJ, Vuchinich RE. To house or not to house: the effects of providing housing to homeless substance abusers in treatment. Am J Public Health. 2005;95:1259–1265.
- Koffarnus MN, Wong CJ, Diemer K, et al. A randomized clinical trial of a therapeutic workplace for chronically unemployed, homeless, alcohol-dependent adults. Alcohol Alcohol. 2011;46:561–569.
- McDonell MG, Leickly E, McPherson S, et al. A randomized controlled trial of ethyl glucuronide-based contingency management for outpatients with co-occurring alcohol use disorders and serious mental illness. Am J Psychiat. 2017;174:370–377.
- Sheehan DV, Lecruibier Y, Sheehan KH, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSMM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–57.
- McDonell MG, Leickly E, McPherson S, et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders with serious mental illness. Am J Addict. 2017;7:673–675.
- McDonell MG, Skalisky J, Leickly E, et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug Alcohol Depend. 2015;157:184–187.